Unlike the nondiabetic population, type 1 diabetes patients rely almost exclusively on stimulated release of adrenal epinephrine to raise blood glucose, due to severely compromised pancreatic glucagon release in response to insulin-induced hypoglycemia [8] and an inability to stop the action of already injected insulin. The gene discussed is GCG; the disease is type 1 diabetes mellitus.